Bacq and Alexander award lecture chemical radioprotection: Past, present and future prospects

International Journal of Radiation Biology

Volumn 73, Issue 4, 1998, Pages 443-450

  Maisin, J R ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; AMINOETHYLISOTHIOURONIUM; BIOLOGICAL RESPONSE MODIFIER; CHIMERIC PROTEIN; CYSTAFOS; CYSTEINE; CYTOKINE; GLUTATHIONE; GLYCAN; MERCAPTAMINE; PHOSPHOROTHIOIC ACID S (3 AMINO 2 HYDROXYPROPYL) ESTER; PHOSPHOROTHIOIC ACID S 3 (3 AMINOPROPYLAMINO)PROPYL ESTER; PHOSPHOROTHIOIC ACID S 3 (3 METHYLAMINOPROPYLAMINO)PROPYL ESTER; PHOSPHOROTHIOIC ACID S [2 (3 METHYLAMINOPROPYLAMINO)ETHYL] ESTER; POLYSACCHARIDE; PROSTAGLANDIN E2; RADIOPROTECTIVE AGENT; SELENIUM; SEROTONIN; SEROTONIN CREATININE SULFATE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHROMOSOME DAMAGE; CONFERENCE PAPER; DRUG MECHANISM; GASTROINTESTINAL TOXICITY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RADIOTHERAPY; WHOLE BODY RADIATION;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0031919872     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098142284     Document Type: Conference Paper

References (38)

1. AINSWORTH, E. J., 1988, From endotoxins to newer immuno-modulators: survival-promoting effects of microbial polysaccharide complexes in irradiated animals. Pharmacology and Therapeutics, 39, 223-241.
2. BACQ, Z. M. and ALEXANDER, P., 1964, Importance for radioprotection of the reaction of cells to sulphydryl and disulphide compounds. Nature, 203, 162.
3. BACQ, Z. M., et al., 1951, Protection contre le rayonnement x par la J-mercaptoethylamine. Archives Internationales de Physiologie, 59, 442-447.
4. BROWN, D. G., et al, 1988, Can WR-2721 be improved upon? Pharmacology and Therapeutics, 39, 157-168.
5. DORIE, M. J., et al., 1991, Protection by interleukin 1 against lung toxicity caused by cytophosphatmide and irradiation. Radiation Research, 128, 316-319.
6. HANSON, W. R. and THOMAS, C., 1983, 16.16-Dimethyl prostaglandin E2 increases survival of murine intestinal stem cells when given before photon radiation. Radiation Research, 96, 393-398.
7. HANSON, W. R., et al., 1988, Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade. Pharmacology and Therapeutics, 39, 347-356.
8. HUGON, J., et al., 1963, Modifications ultra-structurales précoces des cellules des cryptes duodénales de la souris après irradiation par rayons x. Comptes-rendus des séances de la Société de Biologie, 157, 2109-2113.
9. HUGON, J., et al., 1966, Modifications ultrastructurales après radioprotecteurs. International Journal of Radiation Biology, 11, 105-116.
10. MACVITTIE, T. J., et al., 1997, Cytokine-based therapy for radiation-induced myelosuppression. Book of abstracts, 45th Annual Meeting of the Radiation Research Society, S05-1 75, 3-7 May.
11. MAISIN, J. R., 1966, Radiations ionisantes. Radioprotecteurs et Syndrome Gastro-intestinal (Paris: Masson et Cie Editeurs).
12. MAISIN, J. R., 1992, Perspectives in chemical radiation protection. Proceedings of the International Conference on Low Dose Irradiation and Biological Defence Mechanisms, Kyoto, Japan, 12-16 July 1992. International Congress Series (Excerpta Medica), 1013, 135-142.
13. MAISIN, J. R. and DOHERTY, D. G., 1960, Chemical protection of mammalian tissues. Federation Proceedings, 19, 564-572.
14. MAISIN, J. R. and LAMBIET-COLLIER, M., 1967, Influence of a mixture of radioprotectors on the cell renewal in the duodenum of x-irradiated mice. International Journal of Radiation Biology, 13, 35-43.
15. MAISIN, J. R. and MOUTSCHEN, J., 1960, Chemical protection of the alimentary tract of whole-body x-irradiated mice. II. Chromosome breaks and mitotic activity. Experimental Cell Research, 21, 347-352.
16. MAISIN, J. R., et al., 1964, Radioprotecteurs et cancers. Journal Belge de Radiologie, 47, 871-885.
17. MAISIN, J. R., et al., 1965, Tissue and cellular distribution of tritium labelled AET in mice. Journal of the National Cancer Institute, 35, 103-112.
18. MAISIN, J. R., et al., 1968, Reduction of short- and long-term radiation lethality by mixtures of chemical protectors. Radiation Research, 35, 26-44.
19. MAISIN, J. R., et al., 1977, Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation I. Life-shortening. Radiation Research, 71, 119-131.
20. MAISIN, J. R., et al., 1978, Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation II. Causes of death. Radiation Research, 74, 415-435.
21. MAISIN, J. R., et al., 1980, Chemical protection against the long-term effect of whole-body exposure of mice to ionizing radiation III. The effects of fractionated exposure to C57BL mice. Radiation Research, 82, 487-497.
22. MAISIN, J. R., et al., 1986, Polysaccharides induce radioprotection of murine, hemotopoietic stem cells and increase the LD50/30 days. Radiation Research 105, 276-281.
23. MAISIN, J. R., et al., 1993. Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors. Radiation Research, 135, 332-337.
24. MILAS, L., et al., 1984, Effect of tumor type size and endpoint on tumor radioprotection for WR-2721. International Journal of Radiation Oncology, Biology, Physics, 10, 41-48.
25. MILAS, L., et al., 1988, Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio. Pharmacology and Therapeutics, 39, 179-187.
26. MURRAY, D. and MCBRIDE W. H. 1996, Radioprotective agents in Kirk-Othmer. Encyclopedia of Chemical Technology, 4th ed., Vol. 20 (Chichester: John Wiley & Sons), pp. 963-1006.
27. NETA, R., 1988, Role of cytokines in radioprotection. Pharmacology and Therapeutics, 39, 261-266.
28. PATT, H. M., et al., 1949, Cysteine protection against x irradiation. Science, 110, 213-214.
29. RADFORD, I. R., et al., 1994, Radiation response of mouse lymphoid and myeloid cell lines II. Apoptotic death is shown by all lines examined. International Journal of Radiation Biology, 65, 217-227.
30. ROBERTS, D. B., et al, 1993, Interlukin-1 dose, mouse strain and end point as they affect protection of mouse gegunum. Radiation Research, 135, 56-63.
31. ROJAS, A. and DENEKAMP, J., 1984, The influence of x-ray dose levels on normal tissue radioprotection by WR-2721. International Journal of Radiation Oncology, Biology, Physics, 10, 2351-2356.
32. TRAVIS, E. L., 1984, The oxygen dependence of protection by aminothiols: implications for normal tissues and solid tumors. International Journal of Radiation Oncology, Biology, Physics, 10, 1495-1501.
33. UTLEY, J. F., et al, 1984, Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721, International Journal of Radiation Oncology, Biology, Physics, 10, 1525-1528.
34. WEISS, J. F. and SIMIC, M. G., 1988, Introduction: perspectives in radioprotection. Pharmacology and Therapeutics, 39, 1-2.
35. Wu, S. G. and MIYAMOTO, T., 1990, Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha. Radiation Research, 123, 112-115.
36. Wu, S. G, et al, 1989, Radioprotection of C3H mice by recombinant human interleukin-1 alpha. International Journal of Radiation Biology, 56, 485-492.
37. YANAGIHARA, K., et al., 1995, Radiation-induced apoptotic cell death in human gastric epithelial tumour cells; correlation between mitotic death and apoptosis. International Journal of Radiation Biology, 67, 677-685.
38. YUHAS, J. M. and STORER, J. B., 1969, Differential chemoprotection of normal and malignant tissues. Journal of the National Cancer Institute, 42, 331-335.